Many cancer cells remain resistant to receptor-mediated apoptosis—for instance, the TRAIL-mediated apoptotic resistance appears in non-small-cell lung carcinoma, and the TSN showed a sensitivity-enhanced ability for cancer cell apoptosis. Here, TSN is linked to cancer.